Title : BCL2/MDM2 Inhibitor Combo Effective in AML.

Pub. Date : 2019 Feb

PMID : 30647052






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The BCL2 inhibitor venetoclax plus the MDM2 inhibitor idasanutlin may be effective in treating relapsed/refractory acute myeloid leukemia. RG7388 MDM2 proto-oncogene Homo sapiens